首页> 外文期刊>Journal of Clinical Microbiology >Use of protein A-treated sera in unmasking herpes simplex virus type 1 (HSV-1) immunoglobulin A and identifying HSV-1 immunoglobulin G as the predominant neutralizing antibody.
【24h】

Use of protein A-treated sera in unmasking herpes simplex virus type 1 (HSV-1) immunoglobulin A and identifying HSV-1 immunoglobulin G as the predominant neutralizing antibody.

机译:蛋白A处理的血清在揭露1型单纯疱疹病毒(HSV-1)免疫球蛋白A和鉴定HSV-1免疫球蛋白G为主要中和抗体中的用途。

获取原文
获取外文期刊封面目录资料

摘要

Treatment of human sera with protein A reduced the amounts of immunoglobulin G (IgG), IgA, and IgM detected by radial immunodiffusion. This treatment also decreased the amount of herpes-specific IgG and IgM detected by radioimmunoassay, whereas it increased and even unmasked the amount of herpes-specific IgA detected. Comparison of protein A-treated sera with untreated sera indicated that herpes simplex virus type 1 IgG was responsible for more than 92 to 99% of the serum neutralizing activity.
机译:用蛋白A处理人血清可减少通过放射免疫扩散检测到的免疫球蛋白G(IgG),IgA和IgM的量。这种治疗还减少了通过放射免疫测定法检测到的疱疹特异性IgG和IgM的量,而增加甚至揭露了检测到的疱疹特异性IgA的量。将蛋白A处理的血清与未处理的血清进行比较表明,单纯疱疹病毒1型IgG占血清中和活性的92%至99%以上。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号